For: | Abadi ATB. Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required. World J Gastrointest Pharmacol Ther 2017; 8(4): 208-209 [PMID: 29152407 DOI: 10.4292/wjgpt.v8.i4.208] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v8/i4/208.htm |
Number | Citing Articles |
1 |
Max Schmulson, Mohammad Bashashati. Fecal microbiota transfer for bowel disorders: efficacy or hype?. Current Opinion in Pharmacology 2018; 43: 72 doi: 10.1016/j.coph.2018.08.012
|
2 |
Tomohisa Takagi, Yuji Naito, Ryo Inoue, Saori Kashiwagi, Kazuhiko Uchiyama, Katsura Mizushima, Saeko Tsuchiya, Osamu Dohi, Naohisa Yoshida, Kazuhiro Kamada, Takeshi Ishikawa, Osamu Handa, Hideyuki Konishi, Kayo Okuda, Yoshimasa Tsujimoto, Hiromu Ohnogi, Yoshito Itoh. Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. Journal of Gastroenterology 2019; 54(1): 53 doi: 10.1007/s00535-018-1488-5
|
3 |
Phoebe E. Heenan, Jacqueline I. Keenan, Simone Bayer, Myrthe Simon, Richard B. Gearry. Irritable bowel syndrome and the gut microbiota. Journal of the Royal Society of New Zealand 2020; 50(3): 470 doi: 10.1080/03036758.2019.1695635
|